Anti-CO9A2/ COL9A2/ DJ39G22.4 functional antibody

Anti-CO9A2/ COL9A2/ DJ39G22.4 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to COL9A2/COL9A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0806-Ab-1/ GM-Tg-hg-SE0806-Ab-2Anti-Human COL9A2 monoclonal antibodyHuman
GM-Tg-rg-SE0806-Ab-1/ GM-Tg-rg-SE0806-Ab-2Anti-Rat COL9A2 monoclonal antibodyRat
GM-Tg-mg-SE0806-Ab-1/ GM-Tg-mg-SE0806-Ab-2Anti-Mouse COL9A2 monoclonal antibodyMouse
GM-Tg-cynog-SE0806-Ab-1/ GM-Tg-cynog-SE0806-Ab-2Anti-Cynomolgus/ Rhesus macaque COL9A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0806-Ab-1/ GM-Tg-felg-SE0806-Ab-2Anti-Feline COL9A2 monoclonal antibodyFeline
GM-Tg-cang-SE0806-Ab-1/ GM-Tg-cang-SE0806-Ab-2Anti-Canine COL9A2 monoclonal antibodyCanine
GM-Tg-bovg-SE0806-Ab-1/ GM-Tg-bovg-SE0806-Ab-2Anti-Bovine COL9A2 monoclonal antibodyBovine
GM-Tg-equg-SE0806-Ab-1/ GM-Tg-equg-SE0806-Ab-2Anti-Equine COL9A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0806-Ab-1/ GM-Tg-hg-SE0806-Ab-2; GM-Tg-rg-SE0806-Ab-1/ GM-Tg-rg-SE0806-Ab-2;
GM-Tg-mg-SE0806-Ab-1/ GM-Tg-mg-SE0806-Ab-2; GM-Tg-cynog-SE0806-Ab-1/ GM-Tg-cynog-SE0806-Ab-2;
GM-Tg-felg-SE0806-Ab-1/ GM-Tg-felg-SE0806-Ab-2; GM-Tg-cang-SE0806-Ab-1/ GM-Tg-cang-SE0806-Ab-2;
GM-Tg-bovg-SE0806-Ab-1/ GM-Tg-bovg-SE0806-Ab-2; GM-Tg-equg-SE0806-Ab-1/ GM-Tg-equg-SE0806-Ab-2
Products NameAnti-COL9A2 monoclonal antibody
Formatmab
Target NameCOL9A2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COL9A2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0806-Ag-1Recombinant multi-species CO9A2/ COL9A2/ DJ39G22.4 protein
    ORF Viral VectorpGMLP001767human COL9A2 Lentivirus plasmid
    ORF Viral VectorvGMLP001767human COL9A2 Lentivirus particle


    Target information

    Target IDGM-SE0806
    Target NameCOL9A2
    Gene ID1298,12840,362584,694248,607609,101090632,505942,100009713
    Gene Symbol and SynonymsCol9a-2,COL9A2,DJ39G22.4,EDM2,MED,STL5
    Uniprot AccessionQ14055,C0HLN2
    Uniprot Entry NameCO9A2_HUMAN,CO9A2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseJuvenile arthritis
    Gene EnsemblENSG00000049089
    Target ClassificationN/A

    The target: COL9A2, gene name: COL9A2, also named as DJ39G22.4, EDM2, MED, STL5. This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.